Autosomal dominant Parkinson's disease caused by SNCA duplications

Parkinsonism & Related Disorders
Takuya KonnoZbigniew K Wszolek

Abstract

The discovery in 1997 that mutations in the SNCA gene cause Parkinson's disease (PD) greatly advanced our understanding of this illness. There are pathogenic missense mutations and multiplication mutations in SNCA. Thus, not only a mutant protein, but also an increased dose of wild-type protein can produce autosomal dominant parkinsonism. We review the literature on SNCA duplications and focus on pathologically-confirmed cases. We also report a newly-identified American family with SNCA duplication whose proband was autopsied. We found that over half of the reported cases with SNCA duplication had early-onset parkinsonism and non-motor features, such as dysautonomia, rapid eye movement sleep behavior disorder (RBD), hallucinations (usually visual) and cognitive deficits leading to dementia. Only a few cases have presented with typical features of PD. Our case presented with depression and RBD that preceded parkinsonism, and dysautonomia that led to an initial diagnosis of multiple system atrophy. Dementia and visual hallucinations followed. Our patient and the other reported cases with SNCA duplications had widespread cortical Lewy pathology. Neuronal loss in the hippocampal cornu ammonis 2/3 regions were seen in about half of ...Continue Reading

References

Jan 1, 1997·European Neurology·A IshikawaS Tsuji
Aug 15, 1998·Acta Neuropathologica·K WakabayashiH Takahashi
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Apr 17, 2008·Archives of Neurology·Takeshi IkeuchiAtsushi Ishikawa
Jun 30, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Kenya NishiokaNobutaka Hattori
Mar 14, 2012·Archives of Neurology·Gaëtan GarrauxDominique Dive
Jan 4, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Maja KojovicKailash P Bhatia
Feb 28, 2013·Neuromodulation : Journal of the International Neuromodulation Society·Yasushi ShimoNobutaka Hattori
Nov 23, 2013·Parkinsonism & Related Disorders·Shinsuke FujiokaZbigniew K Wszolek
Nov 23, 2013·Parkinsonism & Related Disorders·Marianna Spatola, Christian Wider

❮ Previous
Next ❯

Citations

Jul 1, 2016·Acta Neuropathologica·Catherine LabbéOwen A Ross
Jul 15, 2016·Brain : a Journal of Neurology·Rimona S WeilHuw R Morris
Nov 30, 2016·Human Genetics·Valentina La CognataSebastiano Cavallaro
Jun 2, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Alexandra Perez-SorianoA Jon Stoessl
Jan 21, 2017·Nature Reviews. Neuroscience·D James SurmeierGlenda M Halliday
Mar 12, 2017·Journal of Parkinson's Disease·Robert L Nussbaum
Nov 11, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Susanne A Schneider, Roy N Alcalay
Feb 19, 2017·Cold Spring Harbor Perspectives in Medicine·Robert L Nussbaum
Jul 22, 2018·The FEBS Journal·Dalton James Surmeier
Sep 27, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·K A SenkevichS N Pchelina
Oct 13, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Li GuoM Francesca Cordeiro
Mar 8, 2018·BMC Medicine·Kurt A Jellinger, Amos D Korczyn
Apr 9, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Cornelis BlauwendraatUNKNOWN International Parkinson's Disease Genomics Consortium (IPDGC)
Jan 15, 2019·Current Pharmaceutical Design·Orhan Tansel Korkmaz, Neşe Tunçel
Dec 2, 2015·Nature Genetics·J William LangstonCarrolee Barlow
Jul 16, 2019·Journal of Parkinson's Disease·Diane StephensonUNKNOWN Critical Path for Parkinson’s Consortium
Dec 10, 2019·Brain : a Journal of Neurology·Tomoyuki TaguchiRyosuke Takahashi
Jun 23, 2020·Biological Reviews of the Cambridge Philosophical Society·Yujung ChangJongpil Kim
Jul 3, 2020·Brain : a Journal of Neurology·Yuwen ZhaoBeisha Tang
Feb 20, 2020·Movement Disorders Clinical Practice·Malco RossiMarcelo Merello
Jun 3, 2016·Journal of Neural Transmission·Nicola TambascoPaolo Calabresi
Apr 25, 2018·Frontiers in Neuroscience·Desiree A PiperBirgitt Schüle
Jan 28, 2020·Journal of Parkinson's Disease·Eduardo P De MattosHarm H Kampinga
Jan 11, 2020·Frontiers in Cell and Developmental Biology·Mikhail A ZhukovskyCarmen Valente
May 7, 2020·Frontiers in Neuroscience·Maja MalmbergKariem Ezzat
Apr 20, 2018·Acta Neuropathologica Communications·Airi TarutaniMasato Hasegawa
Mar 1, 2018·Arquivos de neuro-psiquiatria·Oscar S Gershanik
Jul 12, 2018·Proceedings of the National Academy of Sciences of the United States of America·Iryna ProtsBeate Winner
Mar 23, 2017·Current Neurology and Neuroscience Reports·Kaie RosboroughLorraine V Kalia
Oct 18, 2019·Frontiers in Pharmacology·Jack M WebsterLaura J Blair
Dec 21, 2019·Acta Neuropathologica Communications·Sara ElfarrashPoul Henning Jensen
Apr 16, 2019·Frontiers in Neuroscience·H J van Heesbeen, Marten P Smidt
Jan 9, 2019·Frontiers in Neurology·Adam BookUNKNOWN SNCA Multiplication Investigators of the GEoPD Consortium
Apr 22, 2019·Acta Neuropathologica·Javier Alegre-AbarrateguiChristos Proukakis
Dec 25, 2019·Acta Neuropathologica Communications·Diego Perez-RodriguezChristos Proukakis
Jun 28, 2019·Frontiers in Aging Neuroscience·Ningdi LuoJun Liu
Aug 3, 2020·Acta Neuropathologica·José BrásRita Guerreiro
Oct 11, 2020·Brain Sciences·Efthalia AngelopoulouChristina Piperi
Oct 7, 2020·International Journal of Molecular Sciences·Ashley HallKimberley J Billingsley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.